176 related articles for article (PubMed ID: 28230534)
1. Knockdown of antiapoptotic genes in breast cancer cells by siRNA loaded into hybrid nanoparticles.
de Mello LJ; Souza GR; Winter E; Silva AH; Pittella F; Creczynski-Pasa TB
Nanotechnology; 2017 Apr; 28(17):175101. PubMed ID: 28230534
[TBL] [Abstract][Full Text] [Related]
2. siRNA-mediated Bcl-2 and Bcl-xl gene silencing sensitizes human hepatoblastoma cells to chemotherapeutic drugs.
Lei XY; Zhong M; Feng LF; Zhu BY; Tang SS; Liao DF
Clin Exp Pharmacol Physiol; 2007; 34(5-6):450-6. PubMed ID: 17439414
[TBL] [Abstract][Full Text] [Related]
3. Co-delivery of IL17RB siRNA and doxorubicin by chitosan-based nanoparticles for enhanced anticancer efficacy in breast cancer cells.
Alinejad V; Hossein Somi M; Baradaran B; Akbarzadeh P; Atyabi F; Kazerooni H; Samadi Kafil H; Aghebati Maleki L; Siah Mansouri H; Yousefi M
Biomed Pharmacother; 2016 Oct; 83():229-240. PubMed ID: 27372407
[TBL] [Abstract][Full Text] [Related]
4. EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer.
Zhang X; Wang Q; Qin L; Fu H; Fang Y; Han B; Duan Y
Drug Deliv; 2016 Oct; 23(8):2936-2945. PubMed ID: 26739487
[TBL] [Abstract][Full Text] [Related]
5. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.
Beh CW; Seow WY; Wang Y; Zhang Y; Ong ZY; Ee PL; Yang YY
Biomacromolecules; 2009 Jan; 10(1):41-8. PubMed ID: 19072631
[TBL] [Abstract][Full Text] [Related]
6. A biodegradable polymersome containing Bcl-xL siRNA and doxorubicin as a dual delivery vehicle for a synergistic anticancer effect.
Kim HO; Kim E; An Y; Choi J; Jang E; Choi EB; Kukreja A; Kim MH; Kang B; Kim DJ; Suh JS; Huh YM; Haam S
Macromol Biosci; 2013 Jun; 13(6):745-54. PubMed ID: 23613425
[TBL] [Abstract][Full Text] [Related]
7. A strategy using mesoporous polymer nanospheres as nanocarriers of Bcl-2 siRNA towards breast cancer therapy.
Wu X; Zheng Y; Yang D; Chen T; Feng B; Weng J; Wang J; Zhang K; Zhang X
J Mater Chem B; 2019 Jan; 7(3):477-487. PubMed ID: 32254735
[TBL] [Abstract][Full Text] [Related]
8. Co-delivery of Doxorubicin Encapsulated PLGA Nanoparticles and Bcl-xL shRNA Using Alkyl-Modified PEI into Breast Cancer Cells.
Ebrahimian M; Taghavi S; Mokhtarzadeh A; Ramezani M; Hashemi M
Appl Biochem Biotechnol; 2017 Sep; 183(1):126-136. PubMed ID: 28236188
[TBL] [Abstract][Full Text] [Related]
9. The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells.
Cao N; Cheng D; Zou S; Ai H; Gao J; Shuai X
Biomaterials; 2011 Mar; 32(8):2222-32. PubMed ID: 21186059
[TBL] [Abstract][Full Text] [Related]
10. Folate-decorated hydrophilic three-arm star-block terpolymer as a novel nanovehicle for targeted co-delivery of doxorubicin and Bcl-2 siRNA in breast cancer therapy.
Qian J; Xu M; Suo A; Xu W; Liu T; Liu X; Yao Y; Wang H
Acta Biomater; 2015 Mar; 15():102-16. PubMed ID: 25545322
[TBL] [Abstract][Full Text] [Related]
11. Beyond cell death - antiapoptotic Bcl-2 proteins regulate migration and invasion of colorectal cancer cells in vitro.
Koehler BC; Scherr AL; Lorenz S; Urbanik T; Kautz N; Elssner C; Welte S; Bermejo JL; Jäger D; Schulze-Bergkamen H
PLoS One; 2013; 8(10):e76446. PubMed ID: 24098503
[TBL] [Abstract][Full Text] [Related]
12. Enhanced inhibition of bladder cancer cell growth by simultaneous knockdown of antiapoptotic Bcl-xL and survivin in combination with chemotherapy.
Kunze D; Erdmann K; Froehner M; Wirth MP; Fuessel S
Int J Mol Sci; 2013 Jun; 14(6):12297-312. PubMed ID: 23749114
[TBL] [Abstract][Full Text] [Related]
13. AT-101 simultaneously triggers apoptosis and a cytoprotective type of autophagy irrespective of expression levels and the subcellular localization of Bcl-xL and Bcl-2 in MCF7 cells.
Antonietti P; Gessler F; Düssmann H; Reimertz C; Mittelbronn M; Prehn JH; Kögel D
Biochim Biophys Acta; 2016 Apr; 1863(4):499-509. PubMed ID: 26721623
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional peptide-lipid nanocomplexes for efficient targeted delivery of DNA and siRNA into breast cancer cells.
Wan Y; Dai W; Nevagi RJ; Toth I; Moyle PM
Acta Biomater; 2017 Sep; 59():257-268. PubMed ID: 28655658
[TBL] [Abstract][Full Text] [Related]
15. Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells.
Akar U; Chaves-Reyez A; Barria M; Tari A; Sanguino A; Kondo Y; Kondo S; Arun B; Lopez-Berestein G; Ozpolat B
Autophagy; 2008 Jul; 4(5):669-79. PubMed ID: 18424910
[TBL] [Abstract][Full Text] [Related]
16. Polymeric delivery of siRNA for dual silencing of Mcl-1 and P-glycoprotein and apoptosis induction in drug-resistant breast cancer cells.
Aliabadi HM; Mahdipoor P; Uludağ H
Cancer Gene Ther; 2013 Mar; 20(3):169-77. PubMed ID: 23449477
[TBL] [Abstract][Full Text] [Related]
17. Targeting of cell survival genes using small interfering RNAs (siRNAs) enhances radiosensitivity of Grade II chondrosarcoma cells.
Kim DW; Seo SW; Cho SK; Chang SS; Lee HW; Lee SE; Block JA; Hei TK; Lee FY
J Orthop Res; 2007 Jun; 25(6):820-8. PubMed ID: 17343283
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
Deng X; Cao M; Zhang J; Hu K; Yin Z; Zhou Z; Xiao X; Yang Y; Sheng W; Wu Y; Zeng Y
Biomaterials; 2014 May; 35(14):4333-44. PubMed ID: 24565525
[TBL] [Abstract][Full Text] [Related]
19. Targeted therapy against Bcl-2-related proteins in breast cancer cells.
Emi M; Kim R; Tanabe K; Uchida Y; Toge T
Breast Cancer Res; 2005; 7(6):R940-52. PubMed ID: 16280040
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-4 receptor-targeted delivery of Bcl-xL siRNA sensitizes tumors to chemotherapy and inhibits tumor growth.
Guruprasath P; Kim J; Gunassekaran GR; Chi L; Kim S; Park RW; Kim SH; Baek MC; Bae SM; Kim SY; Kim DK; Park IK; Kim WJ; Lee B
Biomaterials; 2017 Oct; 142():101-111. PubMed ID: 28732245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]